The following information was provided by the
Florida Bureau of Radiation Control (
BRC) via email:
Sacred Heart's failure to notify the Florida BRC at the time of the occurrence, 10/15/24, was identified by [the Florida BRC inspector] during a routine inspection.
Sacred Heart intended to inject the patient with 6 mCi of Tc-99m mebrofenin which would travel to the gallbladder. Instead, the patient received 6 mCi of Tc-99m methyl diphosphonate which targeted the bladder wall. The dose received [by the patient] is estimated at 1.6 mGy. Sacred Heart states the syringe had the expected markings of mebrofenin, and the error was caused by the supplier in Alabama.
The patient and primary physician were notified of the occurrence.
Florida Incident Number: FL24-110
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.